These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11518568)

  • 1. Concentration-dependent, temperature-dependent non-Newtonian viscosity of lung surfactant dispersions.
    King DM; Wang Z; Kendig JW; Palmer HJ; Holm BA; Notter RH
    Chem Phys Lipids; 2001 Jul; 112(1):11-9. PubMed ID: 11518568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bulk shear viscosities of endogenous and exogenous lung surfactants.
    King DM; Wang Z; Palmer HJ; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2002 Feb; 282(2):L277-84. PubMed ID: 11792632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mechanisms of lung surfactant inhibition.
    Holm BA; Wang Z; Notter RH
    Pediatr Res; 1999 Jul; 46(1):85-93. PubMed ID: 10400140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
    Holm BA; Wang Z; Egan EA; Notter RH
    Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary importance of zwitterionic over anionic phospholipids in the surface-active function of calf lung surfactant extract.
    Wang Z; Gurel O; Weinbach S; Notter RH
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1049-57. PubMed ID: 9351602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorption of natural lung surfactant and phospholipid extracts related to tubular myelin formation.
    Notter RH; Penney DP; Finkelstein JN; Shapiro DL
    Pediatr Res; 1986 Jan; 20(1):97-101. PubMed ID: 3753757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant.
    Wang Z; Hall SB; Notter RH
    J Lipid Res; 1996 Apr; 37(4):790-8. PubMed ID: 8732779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
    Notter RH; Shapiro DL; Ohning B; Whitsett JA
    Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
    Seeger W; Thede C; Günther A; Grube C
    Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of subfractions of the hydrophobic components of calf lung surfactant.
    Hall SB; Wang Z; Notter RH
    J Lipid Res; 1994 Aug; 35(8):1386-94. PubMed ID: 7989863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The melting of pulmonary surfactant monolayers.
    Yan W; Biswas SC; Laderas TG; Hall SB
    J Appl Physiol (1985); 2007 May; 102(5):1739-45. PubMed ID: 17194731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A.
    Venkitaraman AR; Hall SB; Whitsett JA; Notter RH
    Chem Phys Lipids; 1990 Dec; 56(2-3):185-94. PubMed ID: 2095991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutral lipids induce critical behavior in interfacial monolayers of pulmonary surfactant.
    Discher BM; Maloney KM; Grainger DW; Sousa CA; Hall SB
    Biochemistry; 1999 Jan; 38(1):374-83. PubMed ID: 9890919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.
    Seeger W; Elssner A; Günther A; Krämer HJ; Kalinowski HO
    Am J Respir Cell Mol Biol; 1993 Aug; 9(2):213-20. PubMed ID: 8338688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of lung compliance with calf lung surfactant extract and a surfactant analog in an in situ model of surfactant deficiency in rats.
    Lin WH; Turcotte JG; Parkinson D; Thrall RS
    Respiration; 1996; 63(3):144-9. PubMed ID: 8739483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins.
    Venkitaraman AR; Baatz JE; Whitsett JA; Hall SB; Notter RH
    Chem Phys Lipids; 1991; 57(1):49-57. PubMed ID: 2060063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP-B and SP-C alter diffusion in bilayers of pulmonary surfactant.
    Schram V; Hall SB
    Biophys J; 2004 Jun; 86(6):3734-43. PubMed ID: 15189869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic effects of the hydrophobic surfactant proteins on the early adsorption of pulmonary surfactant.
    Schram V; Hall SB
    Biophys J; 2001 Sep; 81(3):1536-46. PubMed ID: 11509366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.